Aspergillosis Therapy
Studies from University of Perugia further understanding of aspergillosis therapy
Published in Health Risk Factor Week, March 20th, 2007
Data detailed in "Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report" have been presented. "Organ transplant recipients are at increased risk for severe invasive aspergillosis, and amphotericin deoxycholate has been the standard treatment for many years. Currently, however, lipid formulations are preferred due to their few side effects," scientists in Perugia, Italy report.
"Also, a number of new antifungal drugs have been developed including new azoles and echinocandins. Caspofungin is the first of the echinocandin derivatives patented to treat patients with invasive aspergillosis who are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Aspergillosis Therapy
Studies from University Hospital yield new information about aspergillosis therapy - Bacterial Meningitis Therapy
Researchers' work from Wake Forest University, Department of Emergency Medicine focuses on bacterial meningitis therapy - Bird Flu
Bird Flu Booklet - 'What You Need to Know' - is Available from United Poultry Concerns in PDF and Printed Formats - Bird Flu Epidemiology
Scientists at Onderstepoort Veterinary Institute discuss research in bird flu epidemiology - Conjunctivitis Epidemiology
Researchers from Institute Pasteur detail new studies and findings in the area of conjunctivitis epidemiology - DNA Vaccines
Scientists at United States Army Medical Research Institute of Infectious Disease report research in DNA vaccines - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
